ConductScience.org, home

Paper856437

High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis.

Hayes DM and 5 others. Cancer, 1977. Cited by 636 papers, by iCite.

Cite this record

ConductScience Library. High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis. Papers, record 856437. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/856437

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis.
PubMed
Journal
Cancer
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
636
iCite
Relative citation ratio, by iCite
28.1
iCite
Revised in PubMed
2022-03-17
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hayes DMD M
2Cvitkovic EE
3Golbey RBR B
4Scheiner EE
5Helson LL
6Krakoff IHI H

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CisplatinMajor topic
DiuresisMajor topic
KidneyMajor topic
MannitolMajor topic
NeoplasmsMajor topic
Adenocarcinoma
Adult
Aged
Creatinine
Dysgerminoma
Female
Gastrointestinal Neoplasms
Head and Neck Neoplasms
Hearing
Humans
Infusions, Parenteral
Injections, Intravenous
Lung Neoplasms
Male
Middle Aged
Ovarian Neoplasms
Testicular Neoplasms

Source PubMed

Download CSV of topics

Cited by117

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 636 citations.

PMIDTitleJournalYearIn PapersSource
40465128Guidance on the short hydration method for cisplatin administration.Int J Clin Oncol2025https://conductscience.org/library/papers/40465128PubMed
39989079Effect of hydration schedules on dose-limiting toxicity in patients with head and neck squamous cell carcinoma treated with cisplatin.Br J Clin Pharmacol2025https://conductscience.org/library/papers/39989079PubMed
39415423Effect of mannitol on cisplatin-associated acute kidney injury: a target trial emulation.Nephrol Dial Transplant2025https://conductscience.org/library/papers/39415423PubMed
38564107Magnesium supplementation therapy to prevent cisplatin-induced acute nephrotoxicity in pediatric cancer: a randomized phase-2 trial.Int J Clin Oncol2024https://conductscience.org/library/papers/38564107PubMed
37242892Hyaluronic Acid-Based Nanocarriers for Anticancer Drug Delivery.Polymers (Basel)2023https://conductscience.org/library/papers/37242892PubMed
35806229Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity.Int J Mol Sci2022https://conductscience.org/library/papers/35806229PubMed
35413808The effect of mannitol addition to hydration on acute kidney injury event after high dose cisplatin chemotherapy: an ambispective cohort study.BMC Cancer2022https://conductscience.org/library/papers/35413808PubMed
35002308Correlation Between Higher Cumulative Dose of Cisplatin for Concurrent Chemoradiation and Acute Kidney Disease Incidence Among Nasopharyngeal Carcinoma Patients: A Comparative Study.Int J Gen Med2021https://conductscience.org/library/papers/35002308PubMed
33415542Early Physiological and Cellular Indicators of Cisplatin-Induced Ototoxicity.J Assoc Res Otolaryngol2021https://conductscience.org/library/papers/33415542PubMed
32862356Effect of mannitol on acute kidney injury induced by cisplatin.Support Care Cancer2021https://conductscience.org/library/papers/32862356PubMed
32740717Short hydration with 20 mEq of magnesium supplementation for lung cancer patients receiving cisplatin-based chemotherapy: a prospective study.Int J Clin Oncol2020https://conductscience.org/library/papers/32740717PubMed
32720645The identification of dual protective agents against cisplatin-induced oto- and nephrotoxicity using the zebrafish model.Elife2020https://conductscience.org/library/papers/32720645PubMed
32290299Molecular and Cellular Mechanisms of Cytotoxic Activity of Vanadium Compounds against Cancer Cells.Molecules2020https://conductscience.org/library/papers/32290299PubMed
31886208Citrus aurantium Ameliorates Cisplatin-Induced Nephrotoxicity.Biomed Res Int2019https://conductscience.org/library/papers/31886208PubMed
31811602Prognostic significance of hyponatremia induced by systemic chemotherapy in a hospital-based propensity score-matched analysis.Int J Clin Oncol2020https://conductscience.org/library/papers/31811602PubMed
31429065Prevention of Cisplatin-Induced Acute Kidney Injury: A Systematic Review and Meta-Analysis.Drugs2019https://conductscience.org/library/papers/31429065PubMed
31355359Intramuscular administration of hexachloroplatinate reverses cyanide-induced metabolic derangements and counteracts severe cyanide poisoning.FASEB Bioadv2019https://conductscience.org/library/papers/31355359PubMed
30167970Evaluation of the effect of acetazolamide versus mannitol on cisplatin-induced nephrotoxicity, a pilot study.Int J Clin Pharm2018https://conductscience.org/library/papers/30167970PubMed
30157247BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state.PLoS One2018https://conductscience.org/library/papers/30157247PubMed
29765771Reduction in nephrotoxicities using short hydration for chemotherapy containing cisplatin: a consecutive analysis of 467 patients with thoracic malignancies.ESMO Open2018https://conductscience.org/library/papers/29765771PubMed

See all 117 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/856437

GET https://conductscience.org/api/papers/v1/856437/cited_by?page=2